Enhancing lung healing after viral infections by targeting specific lung cells
Improve Lung Regeneration Through Targeting Tuft Cells Following Viral Infection
This study is looking at special lung cells called tuft cells to see how they influence healing after viral infections like COVID-19, with the hope of finding new ways to help your lungs recover better and reduce damage.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10876359 on NIH RePORTER |
What this research studies
This research investigates how certain cells in the lungs, known as tuft cells, affect the healing process after viral infections like COVID-19. It aims to understand the role of these cells in causing lung damage and preventing proper regeneration of lung tissue. By exploring the molecular mechanisms involved, the study seeks to identify ways to enhance lung recovery and reduce inflammation and fibrosis. Patients may benefit from new therapeutic strategies that promote better lung healing following severe viral infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced severe lung injury due to viral infections, particularly those recovering from COVID-19.
Not a fit: Patients with chronic lung diseases unrelated to viral infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for lung damage caused by viral infections, enhancing recovery and quality of life for patients.
How similar studies have performed: While the specific approach of targeting tuft cells is novel, similar research has shown promise in enhancing tissue regeneration in other contexts.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Que, Jianwen — Columbia University Health Sciences
- Study coordinator: Que, Jianwen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.